| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 02/02/2006 | US20060025425 Benzimidazole and pyridylimidazole derivatives |
| 02/02/2006 | US20060025416 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/02/2006 | US20060025413 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 02/02/2006 | US20060025404 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis |
| 02/02/2006 | US20060025403 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/02/2006 | US20060025356 28-epirapalogs |
| 02/02/2006 | CA2574685A1 Quinazolin-4-yl- piperidine and cinnolin-4-yl- piperidine derivatives as pde10 inhibitors for the treatment of cns disorders |
| 02/02/2006 | CA2574167A1 Kynurenic acid amide derivatives as nr2b receptor antagonists |
| 02/02/2006 | CA2573538A1 Inhibitors of vegf receptor and hgf receptor signaling |
| 02/02/2006 | CA2569507A1 Amido compounds and their use as pharmaceuticals |
| 02/01/2006 | EP1621533A1 Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents |
| 02/01/2006 | EP1620445A2 Method and compositions for identifying anti-hiv therapeutic compounds |
| 02/01/2006 | EP1620094A2 Novel chemical compounds |
| 02/01/2006 | EP1619948A1 Sustituted imidazolopyrazine and triazolopyrazine derivatives: gabaa receptor ligands |
| 02/01/2006 | EP1436293B1 Polycyclic compounds having anti-tumor activity |
| 02/01/2006 | CN1729191A Pyrazoloquinolines with immunomodulating activity |
| 02/01/2006 | CN1727339A Tricyclic compounds, their production and use |
| 02/01/2006 | CN1239504C Process for extracting amarylid alkaloid from natural plant |
| 01/31/2006 | US6992089 Anticancer agents; bactericides, fungicides |
| 01/31/2006 | US6992087 Substituted aryl 1,4-pyrazine derivatives |
| 01/31/2006 | US6992078 Solvent extraction, separation, crystallization |
| 01/31/2006 | CA2158855C Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents |
| 01/26/2006 | WO2006010082A1 1,4-disubstituted naphtalenes as inhibitors of p38 map kinase |
| 01/26/2006 | WO2006009655A1 Diphenylimidazopyrimidine and -imidazole amines as inhibitors of b-secretase |
| 01/26/2006 | WO2005090358A3 7h-8,9-dihydro-pyrano (2,3-c) imidazo (1,2a) pyridine derivatives and their use as gastric acid secretion inhibitors |
| 01/26/2006 | WO2005085234A3 Bycyclic anthranilamide derivatives useful as insecticides |
| 01/26/2006 | WO2005069981A3 Method of preparation of benzofuran-2-carboxylic acid {(s)-3-methyl-1-[(4s, 7r)-7methyl-3-oxo-1-(pyridine-2-sulfonyl)-azepan-4-ylcarbamoyl]-butyl}-amide |
| 01/26/2006 | WO2005030713A3 Resolution of a narwedine amide derivative |
| 01/26/2006 | US20060020002 (3a alpha ,4 alpha ,7 alpha ,7a alpha )-Octahydro-3-hydroxy-2-[4-nitro-3-(trifluoromethyl)phenyl]-4,7-methano-1H-isoindol-1-one (2); steroid mimic; competitive inhibitors of intercellular ligand binding reactions involving CAMs and Leukointegrins; anticarcinogenic agent; autoimmune diseases |
| 01/26/2006 | US20060019986 (R/S) rifamycin derivatives, their preparations and pharmaceutical compositions |
| 01/26/2006 | US20060019985 For therapy and prophylaxis of infectious diseases in mammals, both humans and non-humans, having antibacterial activity against drug-resistant bacteria |
| 01/26/2006 | US20060019975 Novel piperidyl derivatives of quinazoline and isoquinoline |
| 01/26/2006 | US20060019960 Antitumoral analogs of ET-743 |
| 01/26/2006 | US20060019959 Novel quinoxalinone derivatives |
| 01/26/2006 | US20060019940 Novel benzoxazocines and their therapeutic use |
| 01/26/2006 | US20060019906 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
| 01/26/2006 | CA2578600A1 Diphenylimidazopyrimidine and -imidazole amines as inhibitors of b-secretase |
| 01/26/2006 | CA2574180A1 Substituted benzothiazoles |
| 01/26/2006 | CA2567569A1 Selective inhibitors against cdk4 and cdk6 having aminothiazole skeleton |
| 01/25/2006 | EP1619210A1 DDS compounds and method for assaying the same |
| 01/25/2006 | EP1619197A1 Substituted Pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-2,4(1H,3H)diones and -4(3H)ones as well as Pyrido[3',2':4,5]furo[3,2-d]-pyrimidin-2,4(1H,3H)diones und -4(3H)ones as inhibitors of TNF-alpha release |
| 01/25/2006 | EP1619196A1 Substituted Pyrido[3',2':4,5]thieno[3,2-d]pyrimidines and Pyrido[3',2':4,5]furo[3,2-d]-pyrimidines for use as inhibitors of PDA-4 and/or TNF-alpha release |
| 01/25/2006 | EP1618110A2 A process for the stereoselective synthesis of lactones |
| 01/25/2006 | EP1617856A2 Somatostatin-dopamine chimeric analogs |
| 01/25/2006 | EP1617806A2 Selective spirocyclic glucocorticoid receptor modulators |
| 01/25/2006 | EP1235825B1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 01/25/2006 | EP1212318B1 Substituted indolinones as tyrosine kinase inhibitors |
| 01/25/2006 | CN1726205A 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
| 01/25/2006 | CN1726201A Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 01/25/2006 | CN1726029A Substituted dihydropyrano indole-3,4-dione derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 01/25/2006 | CN1724535A Production method of 9-nitro camptothecin |
| 01/25/2006 | CN1238356C Method for extracting tetrodotoxin |
| 01/24/2006 | US6989395 TNF inhibitors |
| 01/24/2006 | US6989391 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 01/24/2006 | US6989387 Topoisomerase inhibitors; use treating cancer, as antifungal agent, treating bacterial infections; compounds based on Dibenzo[c,h][1,6]Naphthyridine ring with at least one nitro or amine-based substitution |
| 01/24/2006 | US6989385 Pyrazole compounds useful as protein kinase inhibitors |
| 01/24/2006 | CA2261923C Pyridazino [4,5-b]-quinoline 5-oxide derivatives, their preparation and their use as glycine antagonists |
| 01/24/2006 | CA2195747C New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments |
| 01/19/2006 | WO2006005726A2 Heterocyclic compounds |
| 01/19/2006 | US20060014950 Combining a strong base with a phenyl isonicotinamide in aprotic solvents to form a solutions, then reacting with a cyclohexanone carboxylic acid or ester and water, and acidifying the solution to obtain chemical intermediates for neuropeptide Y antagonists used for treating bulimia, obesity or diabetes |
| 01/19/2006 | US20060014948 e.g 1-[3,5-bis(trifluoromethyl)benzoyl]-2-[3-[(2-methoxyethoxy)-methoxy]-4-methylbenzyl]-4-[2-[(3R)-3-methoxymethyl-morpholino]ethyl]piperazine; treating or preventing Tachykinin-mediated diseases in humans or animals |
| 01/19/2006 | US20060014816 such as: 3-{5-[3-(2-methoxyethoxy)-1-propynyl]-3-thienyl}-6-[(4-methyl-1-piperazinyl)methyl]-1,4-dihydroindeno[1,2-c]pyrazole; diseases resulting from inappropriate activation of the immune system (e.g., autoimmune disorders), allograft rejection, and graft vs. host disease |
| 01/19/2006 | US20060014756 Benzimidazoles |
| 01/19/2006 | US20060014749 (R)-2-{4-[(1H-Indol-2-ylmethyl)-amino]-piperidin-1-yl}-1-(6-methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria |
| 01/19/2006 | US20060014731 Analogs of benzoquinone-containing ansamycins and methods of use thereof |
| 01/18/2006 | EP1615947A2 Process for preparing macrocyclic compounds |
| 01/18/2006 | EP1615932A2 Podophhyllotoxin derivatives as igf-1r inhibitors |
| 01/18/2006 | EP1615919A1 7-([1,4]dioxan-2-yl)-benzothiazole derivatives as adenosine receptor ligands |
| 01/18/2006 | EP1615886A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions |
| 01/18/2006 | EP1207161B1 Novel isoindole derivatives |
| 01/18/2006 | CN1723211A Therapeutic agent for schizophrenia |
| 01/18/2006 | CN1723210A Fused furan compound |
| 01/18/2006 | CN1237061C Chemokine receptor binding heterocyclic compounds |
| 01/18/2006 | CN1237060C Quinzolone derivatives as alpha IA/B adrenergic receptor antagonists |
| 01/17/2006 | US6987187 Process for preparation of amidine derivatives |
| 01/17/2006 | US6987117 Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine |
| 01/17/2006 | US6987109 Solubilized topoisomerase poison agents |
| 01/17/2006 | US6987103 Treatment of chronic myelogenous leukmia, resistant or intolerant to ST1571, involving homoharringtonine alone or combined with other agents |
| 01/12/2006 | WO2005117908A3 Triheterocyclic compounds compositions, and methods for treating cancer or viral diseases |
| 01/12/2006 | US20060009640 Preparation of (-)-galantamine hydrobromide |
| 01/12/2006 | US20060009481 Arylindenopyridines and related therapeutic and prophylactic methods |
| 01/12/2006 | US20060009471 Amido compounds and their use as pharmaceuticals |
| 01/12/2006 | US20060009463 N-(3-rifamycinyl)-carbamates, method of preparing them and their use for treating and preventing tuberculosis |
| 01/12/2006 | CA2572350A1 Tetrahydroquinolines |
| 01/11/2006 | EP1614689A1 Benzoxepino-11-piperidylidene compounds and process for production thereof |
| 01/11/2006 | EP1614683A1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 01/11/2006 | EP1614680A2 Process for preparing 2-iminopyrrolidine derivatives |
| 01/11/2006 | EP1614676A1 Compound inhibiting in vivo phosphorus transport and medicine containing the same |
| 01/11/2006 | EP1613635A2 Solid phase synthesis of antitumoral compounds |
| 01/11/2006 | EP1613626A1 Cyclic benzimidazoles |
| 01/11/2006 | EP1613601A2 Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists |
| 01/11/2006 | EP1370529B1 Substituted dimethyl- 1-(1-phenyl-cyclohexyl)-piperidin-3-yl methyl]-amines and the use of the same as analgesics |
| 01/11/2006 | EP1104297B1 Compositions for the treatment of chronic lymphocytic leukemia |
| 01/11/2006 | CN1720047A PgD2 receptor antagonists for the treatment of inflammatory diseases |
| 01/11/2006 | CN1235882C Aliphatic amino substituted indole quinoline derivatives, their preparation method and pharmaceutical application |
| 01/10/2006 | US6984735 Reacting a dihalaromatic compound with sulfoxide |
| 01/10/2006 | US6984641 Carboline derivatives as PDE5 inhibitors |
| 01/10/2006 | US6984635 Dimerizing agents, their production and use |
| 01/10/2006 | CA2485556C Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 01/10/2006 | CA2383332C Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists |